AI-generated summary
The authors report a 24-week randomized, double-blind trial in which 100 patients with androgenetic alopecia received low-level light therapy on one side of the scalp and sham light on the other. The treated side showed greater hair coverage (14.2% vs. 11.8%) and improvements in several measures, with no serious adverse events reported. The authors conclude the therapy might be effective and safe.
- Participants
- 100
- Who or what was studied
- Patients with androgenetic alopecia
- Limits stated in the abstract
- The abstract does not state the wavelength or device specifications, and the efficacy conclusion is tentative ("might be") given the authors' own description of ongoing debate.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.lww.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Sham, Low-level laser therapy, Androgenetic alopecia, Sham device, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.